Evidence map›Paper›PMID 31465261›Full record

ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2019

The Search for Optimal Stereotactic Body Radiotherapy Dose in Inoperable, Centrally Located Non-Small-Cell Lung Cancer Continues.

Terence T Sio, Pranshu Mohindra, Nathan Y Yu, Jonathan B Ashman, Thomas B Daniels, Kenneth W Merrell, Steven E Schild

Abstract readLetterComment
PubMed Publisher
In one paragraph

Article in Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Biomedical advances and future prospects of high-precision three-dimensional radiotherapy and four-dimensional radiotherapy.Proceedings of the Japan Academy. Series B, Physical and biological sciences · 2023
    Article
  3. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Terence T SioTerence T. Sio, MD, MS, Mayo Clinic Arizona, Phoenix, AZ; Pranshu Mohindra, MD, University of Maryland School of Medicine, Baltimore, MD; Nathan Y. Yu, MD; Jonathan B. Ashman MD, PhD; and Thomas B. Daniels, MD, Mayo Clinic Arizona, Phoenix, AZ; Kenneth W. Merrell, MD, Mayo Clinic, Rochester, MN; and Steven E. Schild, MD; and Mayo Clinic Arizona, Phoenix, AZ.
Pranshu MohindraTerence T. Sio, MD, MS, Mayo Clinic Arizona, Phoenix, AZ; Pranshu Mohindra, MD, University of Maryland School of Medicine, Baltimore, MD; Nathan Y. Yu, MD; Jonathan B. Ashman MD, PhD; and Thomas B. Daniels, MD, Mayo Clinic Arizona, Phoenix, AZ; Kenneth W. Merrell, MD, Mayo Clinic, Rochester, MN; and Steven E. Schild, MD; and Mayo Clinic Arizona, Phoenix, AZ.
Nathan Y YuTerence T. Sio, MD, MS, Mayo Clinic Arizona, Phoenix, AZ; Pranshu Mohindra, MD, University of Maryland School of Medicine, Baltimore, MD; Nathan Y. Yu, MD; Jonathan B. Ashman MD, PhD; and Thomas B. Daniels, MD, Mayo Clinic Arizona, Phoenix, AZ; Kenneth W. Merrell, MD, Mayo Clinic, Rochester, MN; and Steven E. Schild, MD; and Mayo Clinic Arizona, Phoenix, AZ.
Jonathan B AshmanTerence T. Sio, MD, MS, Mayo Clinic Arizona, Phoenix, AZ; Pranshu Mohindra, MD, University of Maryland School of Medicine, Baltimore, MD; Nathan Y. Yu, MD; Jonathan B. Ashman MD, PhD; and Thomas B. Daniels, MD, Mayo Clinic Arizona, Phoenix, AZ; Kenneth W. Merrell, MD, Mayo Clinic, Rochester, MN; and Steven E. Schild, MD; and Mayo Clinic Arizona, Phoenix, AZ.
Thomas B DanielsTerence T. Sio, MD, MS, Mayo Clinic Arizona, Phoenix, AZ; Pranshu Mohindra, MD, University of Maryland School of Medicine, Baltimore, MD; Nathan Y. Yu, MD; Jonathan B. Ashman MD, PhD; and Thomas B. Daniels, MD, Mayo Clinic Arizona, Phoenix, AZ; Kenneth W. Merrell, MD, Mayo Clinic, Rochester, MN; and Steven E. Schild, MD; and Mayo Clinic Arizona, Phoenix, AZ.
Kenneth W MerrellTerence T. Sio, MD, MS, Mayo Clinic Arizona, Phoenix, AZ; Pranshu Mohindra, MD, University of Maryland School of Medicine, Baltimore, MD; Nathan Y. Yu, MD; Jonathan B. Ashman MD, PhD; and Thomas B. Daniels, MD, Mayo Clinic Arizona, Phoenix, AZ; Kenneth W. Merrell, MD, Mayo Clinic, Rochester, MN; and Steven E. Schild, MD; and Mayo Clinic Arizona, Phoenix, AZ.
Steven E SchildTerence T. Sio, MD, MS, Mayo Clinic Arizona, Phoenix, AZ; Pranshu Mohindra, MD, University of Maryland School of Medicine, Baltimore, MD; Nathan Y. Yu, MD; Jonathan B. Ashman MD, PhD; and Thomas B. Daniels, MD, Mayo Clinic Arizona, Phoenix, AZ; Kenneth W. Merrell, MD, Mayo Clinic, Rochester, MN; and Steven E. Schild, MD; and Mayo Clinic Arizona, Phoenix, AZ.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Carcinoma, Non-Small-Cell LungLung NeoplasmsRadiosurgeryDose Fractionation, RadiationHumansNeoplasm Staging

Identifiers

PMID31465261

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.